fludarabine phosphate 25mg/ml concentrate for solution for injection/infusion
actavis group ptc ehf - fludarabine phosphate - concentrate for solution for injection/infusion - 25 milligram(s)/millilitre - purine analogues; fludarabine
fludarabine phosphate 25mg/ml concentrate for solution for injection or infusion
accord healthcare ireland ltd. - fludarabine phosphate - concentrate for solution for injection/infusion - 25 milligram(s)/millilitre - purine analogues; fludarabine
fludarabine phosphate 25mg/ml concentrate for solution for injection or infusion
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - fludarabine phosphate - concentrate for solution for infusion or injection - fludarabine phosphate 25 mg/ml - antineoplastic agents
fludarabine phosphate 25mg/ml concentrate for solution for injection or infusion
accord healthcare limited - fludarabine phosphate - concentrate for solution for infusion - 25 milligram(s)/millilitre - purine analogues; fludarabine
fludarabine phosphate 50mg/2ml concentrate for solution for injection vials
accord-uk ltd - fludarabine phosphate - solution for injection - 25mg/1ml
fludarabine accord healthcare 25 mg/ml inj./inf. sol. (conc.) i.v. vial
accord healthcare b.v. - fludarabine phosphate 25 mg/ml - concentrate for solution for injection/infusion - 25 mg/ml - fludarabine phosphate 25 mg/ml - fludarabine
fludarabine phosphate
accord healthcare limited - fludarabine phosphate - concentrate for solution for infusion or injection - fludarabine phosphate 25 mg/ml - antineoplastic agents
fludarabin ebewe 50 mg2 ml
novartis israel ltd - fludarabine phosphate - concentrate for solution for injection / infusion - fludarabine phosphate 50 mg/dose - fludarabine - fludarabine - palliative treatment of patients with cll refractory to other therapy. treatment of less malignant non-hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. fludarabine is indicated for the initial treatment of patients with b- cell chronic lymphocytic leukaemia (cll) or after first line therapy, in patients with sufficient bone marrow reserves.
fludarabine phosphate 50mg/2ml concentrate for solution for injection vials
sandoz ltd - fludarabine phosphate - solution for injection - 25mg/1ml
fludarabine ebewe fludarabine phosphate 50 mg/2 ml concentrated injection vial
sandoz pty ltd - fludarabine phosphate, quantity: 50 mg - injection, concentrated - excipient ingredients: dibasic sodium phosphate dihydrate; sodium hydroxide; water for injections; nitrogen - fludarabine ebewe is indicated for the treatment of b-cell chronic lymphocytic leukaemia.